Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Recurrent and Metastatic Head and Neck Cancer
NCT00003850Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1999
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Cancer Institute. Started Apr 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00003850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003850.